Author

Thaís Raupp Azevedo

Hospital Moinhos de VentoORCID 0000-0001-8563-3744Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Amanda Paz SantosiD· 1 shared Caroline Nespolo de DavidiD· 1 shared COVIDa study group· 1 shared Fernanda Hammes VarelaiD· 1 shared Fernando Rosado SpilkiiD· 1 shared Gabriela Luchiari Tumioto GianniniiD· 1 shared Gabriela Oliveira ZavagliaiD· 1 shared Gustavo Fioravanti VieiraiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Amanda Paz SantosORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Y380Q novel mutation in receptor-binding domain of SARS-CoV-2 spike protein together with C379W interfere in the neutralizing antibodies interaction

Ivaine Taís Sauthier Sartor, Fernanda Hammes Varela, Mariana Rost Meireles, Luciane Beatriz Kern, Thaís Raupp Azevedo, Gabriela Luchiari Tumioto Giannini, Mariana Soares da Silva, Meriane Demoliner, Juliana Schons Gularte, Paula Rodrigues de Almeida, Juliane Deise Fleck, Gabriela Oliveira Zavaglia, Ingrid Rodrigues Fernandes, Caroline Nespolo de David, Amanda Paz Santos, , COVIDa study group

The paper identifies a novel Y380Q mutation in the SARS-CoV-2 spike protein RBD, along with C379W, which may interfere with neutralizing antibody binding in early pandemic variants.

Diagnostic Microbiology and Infectious Disease · Jan 16, 2022Peer-reviewedGenetic & Genomic Medicine